This activity is supported by an educational grant from Genentech, Inc.
Expiration Date: 4/25/2016
Anti-VEGF is well established as first-line therapy for the treatment of diabetic macular edema (DME) and age-related macular degeneration. What is still being…go to activity»
Expiration Date: 2/1/2016
Several pharmacologic options for the management of obesity have been approved by the US FDA, giving clinicians a range of options for managing patients with obesity…go to activity»
This activity is supported by an educational grant from Eisai, Inc. and Vivus, Inc.
Expiration Date: 12/15/2015
Obesity is associated with a wide range of comorbid conditions, including diabetes, hypertension, sleep apnea, and cardiovascular disease. Clinicians must consider the…go to activity»